# Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

> **NCT00270881** · PHASE1,PHASE2 · COMPLETED · sponsor: **Keio University** · enrollment: 33 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myelogenous Leukemia
- Myelodysplastic Syndrome

## Interventions

- **PROCEDURE:** Cord blood transplantation
- **RADIATION:** TBI
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine

## Key facts

- **NCT ID:** NCT00270881
- **Lead sponsor:** Keio University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-01
- **Final completion:** 2011-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2012-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00270881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00270881, "Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00270881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*